KCM
TECX

Kennedy Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Kennedy Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.7M Sell
282,202
-4,480
-2% -$132K 0.17% 199
2026
Q1 		$8.86M Buy
286,682
+77,457
+37% +$1.91M 0.19% 187
2025
Q4 		$4.36M Buy
209,225
+449
+0.2% +$8.34K 0.09% 320
2025
Q3 		$3.28M Buy
+208,776
New +$4.31M 0.07% 367
2022
Q1 		– Sell
-8,133
Closed -$376K – 637
2021
Q4 		$376K Sell
8,133
-259
-3% -$14.9K 0.01% 582
2021
Q3 		$562K Buy
8,392
+108
+1% +$8.86K 0.01% 568
2021
Q2 		$884K Sell
8,284
-349
-4% -$41.4K 0.02% 530
2021
Q1 		$1.31M Sell
8,633
-6,700
-44% -$1.09M 0.03% 534
2020
Q4 		$2.56M Buy
15,333
+4,824
+46% +$858K 0.06% 473
2020
Q3 		$1.64M Sell
10,509
-159
-1% -$32K 0.05% 506
2020
Q2 		$2.23M Buy
10,668
+475
+5% +$97.9K 0.06% 479
2020
Q1 		$1.9M Sell
10,193
-3,452
-25% -$813K 0.07% 471
2019
Q4 		$3.3M Buy
+13,645
New +$2.63M 0.08% 446

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Kennedy Capital Management's TECX Position: Q2 2026 in Review

Kennedy Capital Management reduced its Tectonic Therapeutic (TECX) stake by 1.6% in Q2 2026, selling an estimated $132K and leaving 282,202 shares worth $9.7M. The position accounts for 0.17% of the portfolio, ranked #199.

Kennedy Capital Management first reported a position in TECX in Q4 2019 and has held it in 13 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Kennedy Capital Management held 282,202 shares of Tectonic Therapeutic worth $9.7M as of Q2 2026.
  • Kennedy Capital Management sold 4,480 Tectonic Therapeutic shares in Q2 2026, an estimated $132K.
  • Tectonic Therapeutic made up 0.17% of Kennedy Capital Management's portfolio in Q2 2026, its #199 holding.
  • Kennedy Capital Management first reported a position in Tectonic Therapeutic in Q4 2019 and has held it in 13 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.